A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19
The precise mechanisms of pathology in severe COVID-19 remains elusive. Current evidence suggests that inflammatory mediators are responsible for the manifestation of clinical symptoms that precedes a fatal response to infection. This review examines the nature of platelet activating factor and emph...
Guardado en:
Autores principales: | Mark Klein MD, Vinh Dao PharmD, BCPS, Fatima Khan MD, MPH |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5edbd1c1c50a4406b493905b9187d87f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Satisfaction With Oral Anticoagulants Among Patients With Atrial Fibrillation: A Prospective Observational Study
por: Shahrzad Salmasi, Msc, et al.
Publicado: (2021) -
Postoperative Nosocomial COVID-19 Infection in Cardiac Surgery: An Uncommon Event With High Mortality Rate
por: Khalid Ridwan, MD, MSc, et al.
Publicado: (2021) -
The Heart-Team Approach for the Treatment of Radiation-Induced Aortic Stenosis and Coronary Artery Disease: A Case ReportNovel Teaching Points
por: Eve Belzile-Dugas, MD, et al.
Publicado: (2021) -
The Dilemma of Peri-Procedural Warfarin Management: A Narrative Review
por: Islam Eljilany MSc, et al.
Publicado: (2021) -
Myocardial fibrosis and its correlation with the predictors of morbidity and mortality in Eisenmenger syndrome
por: K. Divyashree, et al.
Publicado: (2021)